William Parks

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: Inimmune Corporation, Northwest River Supplies, Inc., Swing Sensei, LLC. Active years: 1987-2026.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 66.7

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 37(Granted Patents)

Location History:

Whittier, CA (US) (1987)
New Ringgold, PA (US) (1995)
Moscow, ID (US) (2000 - 2009)
Black Mountain, NC (US) (2015)
Seattle, WA (US) (2020 - 2024)

Company Filing History:

Northwest River Supplies, Inc.

4. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12661411 - MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE (2026-06-23),

2. 11911472 - Monoclonal antibody and vaccine targeting filamentous bacteriophage (2024-02-27),

3. 10835607 - Monoclonal antibody and vaccine targeting filamentous bacteriophage (2020-11-17),

4. 8956239 - Golf ball holding structure (2015-02-17),

5. 7552694 - Frameless pontoon boat (2009-06-30),

6. 7530321 - Frameless pontoon boat (2009-05-12),

7. D431000 - Ornamental frame fitting (2000-09-19),

8. 5454623 - Back rest for use in resting against a tree (1995-10-03),

9. 4668899 - Overhead garage door lock for use with automatic opener (1987-05-26),

Title: The Innovative Contributions of William Parks

Introduction

William Parks is a notable inventor based in Moscow, Idaho, who has made significant contributions to the field of biotechnology. With a total of eight patents to his name, he has focused on developing innovative solutions to combat biofilm formation, which poses challenges in various medical contexts.

Latest Patents

Among his latest patents is a groundbreaking method for reducing or preventing biofilm formation in human subjects. This method involves administering a first composition that includes either an antigen-binding polypeptide that binds to Pf-family bacteriophage or a vaccine against Pf-family bacteriophage. Additionally, he has described an antigen-binding polypeptide that specifically targets a CoaB protein of Pf-family bacteriophage or its fragments. This innovative approach has the potential to significantly impact medical treatments and improve patient outcomes.

Career Highlights

William Parks has worked with various organizations throughout his career, including Northwest River Supplies, Inc. His experience in these companies has allowed him to refine his skills and contribute to important advancements in his field. His dedication to research and development has positioned him as a key figure in biotechnology.

Collaborations

Throughout his career, William has collaborated with notable individuals such as Bryan Dingel and Paul Laszlo Bollyky. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

William Parks is a distinguished inventor whose work in biotechnology has led to significant advancements in the fight against biofilm formation. His innovative patents and collaborations highlight his commitment to improving medical treatments and enhancing patient care.